Treatment for malignant neoplasms of prostate
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
<StructureSection load='' size='340' side='right' caption='Abiraterone acetate' scene='97/978895/Cv/1'> | <StructureSection load='' size='340' side='right' caption='Abiraterone acetate' scene='97/978895/Cv/1'> | ||
*[[Abiraterone acetate]] | *[[Abiraterone acetate]] | ||
| - | *Enzalutamide | + | *[[Enzalutamide]] |
</StructureSection> | </StructureSection> | ||
== References == | == References == | ||
<references/> | <references/> | ||
Revision as of 13:37, 3 March 2024
| |||||||||||
